Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance?
Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis and the number of PDAC-related deaths is rising. Recently the tumour stroma and in particular one of its main components, hyaluronan (HA), have attracted considerable attention as intravenous hyaluronidase treatment together with convent...
Main Authors: | Florian Gebauer, Marius Kemper, Guido Sauter, Peter Prehm, Udo Schumacher |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5459453?pdf=render |
Similar Items
-
The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
by: Wang, L, et al.
Published: (2015) -
Prognostic impact of hyaluronan and its regulators in pancreatic ductal adenocarcinoma.
by: Xiao-Bo Cheng, et al.
Published: (2013-01-01) -
Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
by: Norihiro Sato, et al.
Published: (2016-03-01) -
Immune features of the peritumoral stroma in pancreatic ductal adenocarcinoma
by: Azaz Ahmed, et al.
Published: (2022-09-01) -
Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.
by: Ole Helm, et al.
Published: (2014-01-01)